Most parents learn their baby’s blood type at birth, but only if the hospital has a specific clinical reason to test. Cord blood typing is not a universal part of newborn screening in the United States and many other countries. Whether your baby gets typed depends on your own blood type, your antibody status, and hospital policy. If you’re Rh-negative or have known antibodies, the baby’s blood will almost certainly be tested from cord blood within minutes of delivery. Otherwise, you may leave the hospital without ever learning it.
What Triggers Blood Typing at Birth
When a baby is born in a hospital, the decision to type the cord blood usually hinges on the mother’s blood work from early pregnancy. If you were identified as Rh-negative during prenatal care, the hospital will type the baby to determine whether Rh immune globulin (commonly known by the brand name RhoGAM) is needed after delivery. If you’re blood type O, some hospitals will also type the baby to screen for ABO incompatibility, a condition where the mother’s antibodies attack the baby’s red blood cells. Beyond those two scenarios, many hospitals skip the test entirely.
The debate over whether to test every baby or only those at risk has been going on for decades. Research comparing selective cord blood testing to automatic testing found that selective testing is a reasonable and less expensive approach. However, the same study noted that when newborns are discharged before the third day of life, which is now standard practice in many hospitals, automatic cord blood testing may be the safer option because jaundice from blood type incompatibility sometimes shows up after the family has already gone home.1PubMed. Identifying ABO incompatibility in newborns: selective vs automatic testing In practice, hospital policies vary widely. Some test every cord blood sample, others test selectively, and a few leave the decision to the attending physician.
Finding Out During Pregnancy
Your own blood type is one of the first things established at your initial prenatal visit, typically in the first trimester. The standard blood panel includes ABO group, Rh status, and an antibody screen. This tells your care team whether you carry antibodies that could react with fetal blood cells. What it does not tell you is the baby’s blood type, because the baby’s genetics are a mix of both parents, and you cannot infer the baby’s type from the mother’s alone with certainty.
In pregnancies where the mother is Rh-negative and the father is Rh-positive (or his status is unknown), there is a chance the baby could be Rh-positive. This mismatch can lead to the mother’s immune system producing antibodies against the baby’s red blood cells. Traditionally, all Rh-negative mothers received Rh immune globulin injections as a precaution at around 28 weeks and again after delivery. But newer technology can sometimes answer the question before birth. Cell-free fetal DNA, fragments of the baby’s genetic material that circulate in the mother’s blood, can be analyzed to predict the baby’s Rh status. Studies have demonstrated that this approach reliably determines fetal RhD status and can help target Rh immune globulin injections only to mothers who actually need them, sparing Rh-negative mothers carrying Rh-negative babies from unnecessary treatment.2PubMed Central. Noninvasive Prenatal Diagnosis of Fetal RHD Status Using Cell-free Fetal DNA in Maternal Plasma Next-generation sequencing methods can also determine whether the fetal DNA encodes blood group antigens targeted by a mother’s antibodies, which is useful when the mother has already been sensitized in a prior pregnancy.3PubMed Central. Noninvasive Antenatal Determination of Fetal Blood Group Using Next-Generation Sequencing
This prenatal cell-free DNA testing is more common in some European countries, where it has been incorporated into routine care for Rh-negative women. In the United States, it is available but not yet part of standard screening protocols at most practices. Your provider may order it if you have a complicated antibody history or if prior pregnancies involved hemolytic disease.
Why Rh Incompatibility Gets So Much Attention
Rh incompatibility between mother and baby is the reason blood typing comes up during pregnancy at all. If you are Rh-negative and your baby is Rh-positive, your immune system can recognize the baby’s Rh-positive red blood cells as foreign and start making antibodies against them. This is rarely a problem in a first pregnancy because the immune response takes time to build. But in subsequent pregnancies with another Rh-positive baby, those antibodies can cross the placenta and destroy fetal red blood cells, a condition called hemolytic disease of the fetus and newborn.
Research on Rh-negative pregnancies has shown tangible differences in outcomes even with modern management. A study comparing 100 Rh-negative singleton pregnancies to controls found higher rates of newborn jaundice (about 39% vs. 23%), low birth weight (11% vs. 2%), and neonatal intensive care admission (roughly 30% vs. 18%).4PubMed Central. Analysis of pregnancy and neonatal outcomes in 100 pregnant women with Rh-negative blood type These numbers underscore why hospitals prioritize typing the baby when the mother is Rh-negative. If the baby turns out to be Rh-negative too, the mother can skip the postpartum Rh immune globulin injection and future pregnancies carry no Rh-related risk.
ABO Incompatibility and Newborn Jaundice
Rh incompatibility gets the most press, but ABO incompatibility is actually more common. It occurs most often when a mother with type O blood gives birth to a baby with type A or type B blood. The mother naturally carries anti-A and anti-B antibodies, and some of those can cross the placenta and attack the baby’s red blood cells. The good news is that ABO incompatibility tends to be milder than Rh disease; it rarely causes the severe anemia that Rh incompatibility can.5PubMed Central. Hemolytic Disease of Newborn due to ABO Incompatibility between B Blood Group Mother and A Blood Group Neonate
That said, it’s not always trivial. A prospective study of 210 ABO-incompatible newborns found that about three-quarters developed jaundice significant enough to need phototherapy.6PubMed Central. Cord Blood Bilirubin, Albumin, and Hemoglobin as Predictors of Significant Hyperbilirubinemia in ABO-Incompatible Newborns Cord blood measurements, including bilirubin and hemoglobin levels, can help predict which babies are at highest risk and need early intervention. This is one reason some hospitals type all cord blood: catching ABO incompatibility early lets clinicians start phototherapy before bilirubin climbs dangerously high, rather than waiting for the baby to turn visibly yellow after discharge.
To confirm that an incompatibility is actually causing problems, hospitals use a test called the Direct Antiglobulin Test, sometimes referred to as the direct Coombs test. It detects whether the mother’s antibodies have attached to the baby’s red blood cells.7JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. Cord Direct Antiglobulin Test for Predicting the Need for Phototherapy in Neonates with ABO Incompatibility A positive result doesn’t always mean the baby will develop severe jaundice, but it does flag the baby for closer monitoring.
Why a Newborn’s Blood Type Result Can Be Tricky
One thing that surprises many parents is that a blood type assigned at birth is not always the final word. Newborn blood typing has quirks that don’t apply to adults. Babies have immature immune systems, so they don’t yet produce their own antibodies against foreign blood types. Standard blood typing in adults uses both “forward typing” (testing the red blood cells for A and B antigens) and “reverse typing” (testing the serum for anti-A and anti-B antibodies). In newborns, only forward typing is reliable because the baby’s serum antibodies are mostly borrowed from the mother and fade within a few months.
The A and B antigens on a newborn’s red blood cells are also less developed than they will be later. A baby who will eventually test as type A might show weak reactions at birth, and in rare cases a baby’s cord blood can pick up contamination from maternal blood during delivery, producing a misleading result. For these reasons, most blood banks consider a newborn’s type to be provisional. If your child ever needs a transfusion or you need a definitive type for medical records, the test is typically repeated after six months of age, when the antigens have matured.
The Weak D Problem
Even something as seemingly straightforward as Rh-positive or Rh-negative can get complicated. Some people carry what is called a weak D phenotype, meaning their red blood cells have a reduced amount of the Rh D antigen. Depending on the testing method used, a weak D sample might register as Rh-positive on one machine and Rh-negative on another. This inconsistency creates real clinical headaches, especially in newborns. A baby with weak D typed as Rh-negative might lead the care team to skip Rh immune globulin for an Rh-negative mother, when in fact the baby’s cells do carry enough D antigen to sensitize her.8PubMed Central. Weak D phenotype in transfusion medicine and obstetrics: Challenges and opportunities
Molecular genotyping, which looks at the DNA itself rather than relying on how the antigen reacts with test reagents, can resolve the ambiguity. Some weak D variants behave clinically like Rh-positive and some like Rh-negative, and the only way to tell them apart reliably is at the genetic level. This level of testing is not done routinely on every baby, but it comes into play when serological results are unclear or when a woman with weak D is planning future pregnancies.
Home Blood Typing Kits
If the hospital didn’t type your baby, or if you gave birth outside a hospital setting, you might be tempted to try an at-home blood typing kit. These kits use reagent cards: you apply a drop of blood, and the card’s dried antibodies cause visible clumping if the corresponding antigen is present. They’re inexpensive, widely available online, and marketed as easy to use. The reality is more nuanced.
Testing under controlled conditions found that one popular commercial kit (the Eldon Home Kit) performed comparably to the industry standard, but another kit’s accuracy degraded when stored in high temperatures.9PubMed. Accuracy of user-friendly blood typing kits tested under simulated military field conditions That was the kit’s performance under ideal interpretation. When researchers looked at how well actual users could read and interpret the results, consistency dropped to about 80%, and accuracy varied significantly with the user’s level of medical training.10PubMed. Diagnostic accuracy of a point-of-care blood typing kit conducted by potential end users People with more medical background got more reliable results. For a parent trying to type a squirming infant’s heel-prick blood at home, interpretation errors are a real concern.
An at-home kit can give you a rough answer for curiosity’s sake, but no hospital or blood bank will accept a home kit result for clinical decisions. If you need a confirmed blood type for your child, a simple lab draw at your pediatrician’s office is more reliable and typically covered by insurance when medically indicated.
Can You Predict Your Baby’s Blood Type from the Parents?
Many parents try to work backward from their own blood types to guess what the baby will be. You can narrow the possibilities, but you often can’t pin it down to a single answer. If both parents are type O, the baby will be type O. If one parent is type A and the other is type O, the baby will be either A or O, but you won’t know which until you test. The more heterozygous (carrying one copy of different versions of the gene) the parents are, the wider the range of outcomes. And most people don’t know whether they’re homozygous or heterozygous for their blood type without genetic testing.
The same uncertainty applies to Rh status. An Rh-positive parent could be carrying one Rh-positive gene and one Rh-negative gene. If both parents are Rh-positive carriers of the negative gene, there’s about a one-in-four chance of an Rh-negative baby. This is why fathers’ Rh status alone can’t substitute for testing the baby directly in clinical situations where it matters.
Blood Typing and Paternity Questions
Blood type has a long history as an informal paternity indicator. If two type O parents have a baby who tests as type AB, something doesn’t add up, because type O parents can only produce type O children. But blood typing is far blunter than DNA paternity testing. Research comparing ABO phenotype-based exclusion to genotype-based exclusion found a meaningful gap: when investigators looked at 35 cases where the alleged father was excluded by other methods, ABO phenotype alone only flagged about 20% of them, while ABO genotyping caught roughly 34%.11PubMed Central. Blood Group ABO Genotyping in Paternity Testing In other words, blood typing misses most non-paternity cases. Modern DNA testing is far more powerful for this purpose, and blood type alone should never be treated as proof of anything in either direction.
Rare Blood Types That Defy Standard Testing
Very occasionally, a baby’s blood type result doesn’t fit any expected pattern, and the explanation turns out to be a genuinely rare phenotype. The most famous example is the Bombay phenotype, first identified in Mumbai. People with this phenotype lack the H antigen, which is the precursor molecule that gets modified to produce A or B antigens. Without it, their red blood cells look like type O on standard testing, but they carry antibodies against the H antigen itself, meaning they can’t receive blood from any regular ABO donor.12PubMed Central. Bombay Blood Group Phenotype Misdiagnosed As O Phenotype: A Case Report A related variant, the para-Bombay phenotype, occurs when the gene responsible for placing H antigen on red blood cells is nonfunctional but a backup gene allows weak H antigen to appear, picked up from body secretions.13PubMed Central. Identification and structural analysis of a novel FUT1 c. 789C >A variant and previously reported para‐Bombay alleles using an α2FucT1 structural model
These variants are extremely uncommon, but when they occur in a newborn, the initial type assigned at birth can be flatly wrong. A baby with the Bombay phenotype will look like type O until specialized testing reveals the absence of H antigen. This typically only comes to light if the child later needs a blood transfusion and unexpected antibody reactions are detected. For the vast majority of families, these rare phenotypes will never be relevant, but they illustrate why a birth blood type is a screening result rather than a definitive molecular diagnosis.
When to Actively Ask for Your Baby’s Blood Type
If knowing your baby’s blood type matters to you for personal or practical reasons, there are a few situations where it pays to be proactive. If you’re delivering at a birth center or at home, cord blood testing may not be part of the standard protocol. You can ask your midwife in advance whether they collect cord blood and whether typing is available. If you have a known antibody from a prior pregnancy or prior transfusion, make sure your prenatal records are up to date and that the delivering facility is aware, because the baby’s type will factor directly into the postnatal care plan.
For parents without medical risk factors who simply want to know, a pediatric blood draw at a later well-child visit is the most straightforward route. Waiting until the baby is at least a few months old gives a more reliable result since the antigens are better developed and maternal antibodies have cleared. Most pediatricians are happy to add a blood type to a routine lab panel if you ask, though it may not be covered by insurance when there’s no clinical indication. A basic ABO and Rh type is inexpensive even when paid out of pocket, usually in the range of a standard lab fee.
Genetic testing services that process saliva or cheek swabs don’t typically report classical blood type as part of their standard panels, though some consumer genomics companies have added it as an optional report. The accuracy is high for ABO and standard Rh status but will miss rare variants like Bombay or weak D unless the platform specifically tests for those alleles, which most do not.